Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Blood Pressure Monitoring Protocol After IABP Insertion

Initial Monitoring Setup

  • The European Society of Cardiology recommends invasive arterial pressure monitoring via an arterial line as the standard of care for all IABP patients, with the arterial line preferably placed in the right radial artery to avoid potential interference from the IABP 1, 2, 3
  • Continuous ECG monitoring must be implemented alongside blood pressure monitoring for patients with an IABP, according to the European Heart Journal 1, 2
  • Standard non-invasive monitoring of heart rate, rhythm, respiratory rate, and oxygen saturation should also be maintained for patients with an IABP, as recommended by the European Journal of Heart Failure 1, 2

Blood Pressure Targets

  • The European Heart Journal recommends maintaining mean arterial pressure above 90 mmHg or no more than 30 mmHg below baseline to ensure adequate coronary perfusion in patients with an IABP 4
  • Systolic blood pressure should be controlled between 100-120 mmHg in most cases for patients with an IABP, according to the European Heart Journal 5

Additional Hemodynamic Monitoring

  • Consider pulmonary artery catheter monitoring for patients with refractory symptoms, particularly those with hypotension and hypoperfusion, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 2
  • Serial echocardiography should be used to evaluate ventricular function and response to IABP support, especially in hemodynamically unstable patients, according to Intensive Care Medicine 3, 6
  • Monitor for signs of improved tissue perfusion including improved urine output, decreasing lactate levels, and improved mental status in patients with an IABP, as recommended by Intensive Care Medicine 3, 6

Medication Management During Monitoring

  • For patients with severe hypertension despite IABP, consider adding vasodilators, such as sodium nitroprusside, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 5
  • Beta-blockers should be avoided in patients with frank cardiac failure evidenced by pulmonary congestion or signs of a low-output state, according to Circulation 7
  • Inotropic agents, such as dobutamine, may be considered to increase cardiac output in patients with cardiogenic shock, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 2

Monitoring for Complications

  • Monitor renal function with daily measurement of BUN/urea, creatinine, and electrolytes in patients with an IABP, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 2

Documentation Requirements

  • Record hemodynamic parameters at regular intervals, typically hourly, for patients with an IABP, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 2
  • Document IABP settings, including timing, ratio, and augmentation pressures, as recommended by Praxis Medical Insights 4
  • Maintain an accurate fluid balance chart for patients with an IABP, as recommended by the European Journal of Heart Failure and the European Heart Journal 1, 2

Special Considerations

  • For patients with right ventricular failure, optimize right ventricular preload and consider adding pulmonary vasodilators, as recommended by Praxis Medical Insights 4
  • Early consideration of more advanced mechanical circulatory support is recommended for patients with refractory cardiogenic shock despite IABP optimization, according to Praxis Medical Insights 4

REFERENCES

4

Management Strategies for Low IABP Augmentation Pressures [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025